UNSPSC 51273903: Aloh/diphenhydramine/lidocaine/magnesium/simethicone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT300. This VA Drug Class (NT300) classifies this compound as belonging to the group ANESTHETICS, MUCOSAL.

UNSPSC 51273903 Aloh/diphenhydramine/lidocaine/magnesium/simethicone is a Commodity code that does not align with the state and local procurement activity posted under it. The three recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which fall within the narrow chemical formulation named in the code itself. The code shows little relevant recent activity, and the mismatch suggests a cataloging inconsistency rather than a meaningful signal about actual state and local buying patterns for this specific medication combination.

The posted opportunities instead reflect broader state and local purchasing in pharmaceutical supply, where Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (due July 26, 2023), the Texas Health and Human Services Commission posted an RFI exploring direct-to-manufacturer prescription contracting (due April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities (due March 26, 2026). These solicitations span county health programs, state HHS agencies, and cooperative purchasing vehicles, but they do not specifically target the medication combination identified by code 51273903. Business development professionals should treat this code as inactive for practical procurement purposes and monitor higher-level pharmaceutical and OTC product codes instead.